CHIMERA Challenge Task 2 and 3: Response Subtypes Classification and Progression Survival Prediction in Bladder Cancer Patients using Multimodal Datasets

• URL: http://arxiv.org/abs/2609.09510v1
• Date: Tue, 08 Sep 2026 22:52:55 GMT
• Title: CHIMERA Challenge Task 2 and 3: Response Subtypes Classification and Progression Survival Prediction in Bladder Cancer Patients using Multimodal Datasets
• Abstract summary: CHIMERA was established as a multimodal AI challenge to benchmark prediction in HR-NMIBC.<n>13 top-performing models were selected for benchmarking.<n>Findings highlight barriers to transportability and the importance of missingness-aware modeling.
• Score: 0.04551401337908834
• License: http://creativecommons.org/licenses/by-nc-sa/4.0/
• Abstract: High-risk non-muscle-invasive bladder cancer (HR-NMIBC) carries substantial risks of recurrence and progression, while current clinical risk stratification remains limited. CHIMERA was established as a multimodal AI challenge to benchmark prediction in HR-NMIBC under standardized evaluation. Task BRS predicts RNA-seq-defined BCG Response Subtypes from histopathology and structured clinicopathological data, whereas Task Progression models time-to-progression using histopathology, structured data, and RNA sequencing. A multimodal dataset of 368 patients was divided into public training and hidden validation and test sets. In total, 159 submissions were made, and 13 top-performing models were selected for benchmarking. The best models achieved a weighted F1 score of 0.73 for Task BRS and a C-index of 0.68 for Task Progression. Post-challenge analyses revealed task-dependent modality contributions, cohort-dependent performance degradation, and sensitivity to missing structured data. In Task BRS, histopathology partly compensated for pathology-derived structured variables, whereas progression models showed greater dependence on complementary inputs. Cross-model error analysis further identified patients that were consistently difficult across different architectures, with T1 substage associated with prediction difficulty. These findings highlight barriers to transportability and the importance of missingness-aware modeling and independent multi-institutional validation. CHIMERA provides a standardized multimodal benchmark for bladder cancer and a framework for studying not only model performance, but also robustness, information sufficiency, and patient-level prediction failure.

Related papers

• Dementia Etiology Diagnosis via Collaborative Meta Knowledge Enhancement [81.27196033392559]
  We propose a Collaborative Meta Knowledge Enhancement (COME) framework for dementia etiology diagnosis.<n>COME injects multi-center acquisition semantics, source identifiers, and modality indicators as heterogeneity-aware embeddings into a unified Transformer architecture for scale-up training.<n>Our method achieves state-of-the-art in-domain performance with a mean macro-averaged AUC of 85.62% and a 4.29-point gain over the strongest baseline.
  arXiv  Detail & Related papers  (2026-07-24T04:26:47Z)
• The Good, the Bad, and the Brittle: Benchmarking Robustness and Generalisation of Histopathology Foundation Models [0.1274452325287335]
  We benchmarked twelve pathology foundation models (PFMs) and ResNet baselines.<n>PFMs consistently outperform CNNs in both robustness and domain generalisation, yet model scaling shows diminishing returns.<n> NR-Kfold analysis reveals systematic accuracy loss and increased variability when training-test similarity is broken.
  arXiv  Detail & Related papers  (2026-07-05T16:49:09Z)
• Benchmarking Machine Learning Models for Multi-Omics-Based Breast Cancer Prediction [0.0]
  Estrogen Receptor (ER) status is a critical biomarker in breast cancer diagnosis, prognosis, and treatment selection.<n>This study presents a systematic benchmarking analysis of classical machine learning models for ER status prediction.
  arXiv  Detail & Related papers  (2026-06-27T02:46:40Z)
• Multimodal Ordinal Modeling of Alzheimer's Disease Severity Using Structural MRI and Clinical Data [0.9786690381850356]
  Alzheimer's disease (AD) requires accurate and scalable tools for assessing disease severity.<n>We propose an attention-enhanced machine learning framework with ordinal regression for automated and interpretable AD severity staging.
  arXiv  Detail & Related papers  (2026-06-10T08:26:11Z)
• A Systematic Evaluation of Imbalance Handling Methods in Biomedical Binary Classification [9.011003401201323]
  This study systematically examined the impact of imbalance handling methods (IHMs) on predictive performance in biomedical binary classification.<n>We evaluated five representative IHMs: random undersampling (RUS), random oversampling (ROS), SMOTE, re-weighting (RW), and direct F1-score optimization (DMO)<n>Clear benefits were observed for more complex models and unstructured data.
  arXiv  Detail & Related papers  (2026-05-13T21:57:38Z)
• Investigating the Impact of Histopathological Foundation Models on Regressive Prediction of Homologous Recombination Deficiency [52.50039435394964]
  We systematically evaluate foundation models for regression-based tasks.<n>We extract patch-level features from whole slide images (WSI) using five state-of-the-art foundation models.<n>Models are trained to predict continuous HRD scores based on these extracted features across breast, endometrial, and lung cancer cohorts.
  arXiv  Detail & Related papers  (2026-01-29T14:06:50Z)
• Deep Survival Analysis for Competing Risk Modeling with Functional Covariates and Missing Data Imputation [13.108896747775063]
  We introduce the Functional Competing Risk Net (FCRN), a unified deep-learning framework for discrete-time survival analysis under competing risks.<n>By combining a micro-network Basis Layer for functional data representation with a gradient-based imputation module, FCRN simultaneously learns to impute missing values and predict event-specific hazards.
  arXiv  Detail & Related papers  (2025-09-29T18:33:00Z)
• Adaptable Cardiovascular Disease Risk Prediction from Heterogeneous Data using Large Language Models [70.64969663547703]
  AdaCVD is an adaptable CVD risk prediction framework built on large language models extensively fine-tuned on over half a million participants from the UK Biobank.<n>It addresses key clinical challenges across three dimensions: it flexibly incorporates comprehensive yet variable patient information; it seamlessly integrates both structured data and unstructured text; and it rapidly adapts to new patient populations using minimal additional data.
  arXiv  Detail & Related papers  (2025-05-30T14:42:02Z)
• GenBench: A Benchmarking Suite for Systematic Evaluation of Genomic Foundation Models [56.63218531256961]
  We introduce GenBench, a benchmarking suite specifically tailored for evaluating the efficacy of Genomic Foundation Models. GenBench offers a modular and expandable framework that encapsulates a variety of state-of-the-art methodologies. We provide a nuanced analysis of the interplay between model architecture and dataset characteristics on task-specific performance.
  arXiv  Detail & Related papers  (2024-06-01T08:01:05Z)
• Bootstrapping Your Own Positive Sample: Contrastive Learning With Electronic Health Record Data [62.29031007761901]
  This paper proposes a novel contrastive regularized clinical classification model. We introduce two unique positive sampling strategies specifically tailored for EHR data. Our framework yields highly competitive experimental results in predicting the mortality risk on real-world COVID-19 EHR data.
  arXiv  Detail & Related papers  (2021-04-07T06:02:04Z)
• MIA-Prognosis: A Deep Learning Framework to Predict Therapy Response [58.0291320452122]
  This paper aims at a unified deep learning approach to predict patient prognosis and therapy response. We formalize the prognosis modeling as a multi-modal asynchronous time series classification task. Our predictive model could further stratify low-risk and high-risk patients in terms of long-term survival.
  arXiv  Detail & Related papers  (2020-10-08T15:30:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.